Behind-the-Scenes a...
Health Care: Drugs
Titan Pharmaceuticals Incorporated (TTNP: OTC)
$0.54 -0.01 | -1.82%
05/22/13 - 10:55 AM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2007 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -15.18M | -15.20M | -6.83M | -17.65M |
| Operating Gains/Losses | 0.00 | 0.00 | 0.00 | -359.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -926.00K | -2.50M | -1.16M | 0.00 |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -1.02M | 2.33M | 2.12M | -4.00K |
| (Decrease) Increase In Other Current Liabilities | 417.00K | -744.00K | 308.00K | 866.00K |
| (Increase) Decrease In Other Working Capital | 14.38M | 0.00 | 0.00 | 0.00 |
| Other Non-Cash Items | 4.00M | 624.00K | 865.00K | 1.39M |
| Net Cash From Continuing Operations | 1.83M | -14.48M | -4.66M | -15.19M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 1.83M | -14.48M | -4.66M | -15.19M |
| Sale of Property, Plant & Equipment | 0.00 | 2.00K | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 56.50M |
| Purchases of Property, Plant & Equipment | -1.15M | -236.00K | -28.00K | -212.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | -56.30M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -1.15M | -234.00K | -28.00K | -19.00K |
| Issuance of Debt | 0.00 | 16.50M | 5.00M | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 12.41M | 0.00 | 0.00 | 31.21M |
| Repayment of Long-Term Debt | -393.00K | -7.56M | -435.00K | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 8.00M | 0.00 | 0.00 |
| Net Cash From Financing Activities | 12.02M | 16.94M | 4.56M | 31.21M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 12.70M | 2.23M | -120.00K | 16.00M |
Portfolios with TTNP
- Portfolio NameUser Type
- UserJKE 1
Latest TTNP Headlines from TheStreet
- FDA Rejection of Titan's Probuphine Looks Like a Mugging 05.01.13 | 05:05 am
- Biotech Stock Mailbag: Exact Sciences, Galena, Titan, Arena, Breakthrough Therapy 04.12.13 | 06:04 am
- Titan Pharma: FDA Panel Live Blog 03.21.13 | 07:03 am
- The Next Big Thing In Biotech: Titan
03.14.13 | 12:03 pm - Best And Worst FDA Drug Approval Stocks of 2013 03.12.13 | 08:03 am
- Play TheStreet's FDA Drug Approval Contest 03.05.13 | 12:03 pm
- Biotech Stock Mailbag: Northwest Bio, Amarin, Titan Pharma 02.15.13 | 06:02 am
- Titan Pharma: Run-Up Trade Into March FDA Panel 01.31.13 | 06:01 am
Press Releases for TTNP
- Top Stocks On The Move: Medi Swipe Inc., New Western Energy Corp., Titan Pharmaceuticals Inc., And Advanced Cell Technology Inc. - PR Newswire 01.07.13 | 09:01 am
- Titan Reports Fourth Quarter 2010 Fanapt® Royalty - PR Newswire 02.03.11 | 09:02 pm
Partner Headlines for TTNP
